- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.05. | CLEO DIAGNOSTICS LTD: Cleansing Notice | - | ASX | ||
| CLEO DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 28.05. | CLEO DIAGNOSTICS LTD: Application for quotation of securities - COV | - | ASX | ||
| 20.05. | CLEO DIAGNOSTICS LTD: CLEO Establishes U.S. Reimbursement Pathway | - | ASX | ||
| 29.04. | CLEO DIAGNOSTICS LTD: Quarterly activities and cashflow report | - | ASX | ||
| 27.04. | CLEO DIAGNOSTICS LTD: CLEO Commences Kit Manufacturing Ahead of FDA Submission | - | ASX | ||
| 31.03. | CLEO DIAGNOSTICS LTD: Sample Collection Completion for Pivotal US Clinical Trial | 2 | ASX | ||
| 23.03. | Cleo Diagnostics Optimises Biomarker Panel for Ovarian Cancer Blood Test Ahead of FDA Submission | 3 | smallcaps.com.au | ||
| 22.03. | CLEO DIAGNOSTICS LTD: CLEO Optimises Biomarker Panel Ahead of FDA Submission | - | ASX | ||
| 25.02. | CLEO DIAGNOSTICS LTD: Appendix 4D and Half Yearly Accounts | - | ASX | ||
| 18.02. | Cleo Diagnostics Selects Next-Generation Ella Platform to Deliver Ovarian Cancer Blood Test | 1 | smallcaps.com.au | ||
| 17.02. | CLEO DIAGNOSTICS LTD: CLEO Confirms Next-Gen Platform for Ovarian Cancer Test | - | ASX | ||
| 05.01. | CLEO DIAGNOSTICS LTD: Ceasing to be a substantial holder | 2 | ASX | ||
| 29.12.25 | CLEO DIAGNOSTICS LTD: Chairman's End of Year Letter to Shareholders | 1 | ASX | ||
| 29.12.25 | CLEO DIAGNOSTICS LTD: Cleansing Notice | 1 | ASX | ||
| 29.12.25 | CLEO DIAGNOSTICS LTD: Notification regarding unquoted securities - COV | 1 | ASX | ||
| 29.12.25 | CLEO DIAGNOSTICS LTD: Application for quotation of securities - COV | 1 | ASX | ||
| 29.12.25 | CLEO DIAGNOSTICS LTD: Application for quotation of securities - COV | 2 | ASX | ||
| 17.12.25 | CLEO DIAGNOSTICS LTD: Proposed issue of securities - COV | - | ASX | ||
| 17.12.25 | CLEO DIAGNOSTICS LTD: CLEO Raises $5m to Support U.S. Market Launch | - | ASX | ||
| 16.12.25 | CLEO DIAGNOSTICS LTD: Trading Halt | - | ASX |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 37,260 | +1,61 % | DAX-Verlierer: Die fünf Verlierer des Monats im DAX - Diese Werte enttäuschten | © Foto: Julian Stratenschulte/dpa Der Mai 2026 brachte für Anleger Höhenflüge und Abstürze. Ein Überblick über die fünf schwächsten Aktien im DAX.Während einige DAX-Werte im Mai deutliche Kursgewinne... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,37 | -0,05 % | BrightSpring Health Services, Inc. - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 34,840 | +0,55 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,180 | +1,17 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 15,380 | +0,07 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| GENEDX | 52,26 | +0,10 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| BILLIONTOONE | 97,20 | +0,01 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROGYNY | 25,850 | -0,04 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| ONCOLOGY INSTITUTE | 4,870 | 0,00 % | Oncology Institute, Inc. - 8-K, Current Report | ||
| CARL ZEISS MEDITEC | 26,740 | +0,38 % | Aktien - Shortseller-Positionen: Carl Zeiss Meditec, Evotec, HelloFresh, Kontron, LPKF Laser, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| VIVOS THERAPEUTICS | 0,856 | -1,04 % | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing | LITTLETON, Colo., June 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,850 | +0,07 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| UNITEDHEALTH | 346,20 | -0,17 % | Aktien New York Ausblick: Techwerte unter Druck nach KI-Ausblick von Broadcom | NEW YORK (dpa-AFX) - Ein enttäuschender Ausblick des Chipkonzerns Broadcom dürfte am Donnerstag für Moll-Stimmung an der Technologiebörse Nasdaq sorgen. Der Broker IG taxierte den viel beachteten Branchenindex... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 9,360 | +0,11 % | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| HEARTFLOW | 28,110 | +0,04 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen |
CLEO DIAGNOSTICS LTD gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CLEO DIAGNOSTICS LTD finden Sie auf Wallstreet Online.